Clinical Trial Update: Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study

View source ↗

Summary

This entry provides an update on the Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study (NCT02735447) sponsored by La-ser Europe Limited, focusin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sporadic Inclusion Body Myositis

Snippet

Sponsor: La-ser Europe Limited | Conditions: Sporadic Inclusion Body Myositis | Status: UNKNOWN